Oxidative Phosphorylation
"Oxidative Phosphorylation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds.
Descriptor ID |
D010085
|
MeSH Number(s) |
G02.111.665.550 G03.295.631 G03.796.550
|
Concept/Terms |
Oxidative Phosphorylation- Oxidative Phosphorylation
- Phosphorylation, Oxidative
- Oxidative Phosphorylations
- Phosphorylations, Oxidative
|
Below are MeSH descriptors whose meaning is more general than "Oxidative Phosphorylation".
Below are MeSH descriptors whose meaning is more specific than "Oxidative Phosphorylation".
This graph shows the total number of publications written about "Oxidative Phosphorylation" by people in this website by year, and whether "Oxidative Phosphorylation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 |
1995 | 0 | 2 | 2 |
1998 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2010 | 1 | 1 | 2 |
2011 | 1 | 2 | 3 |
2012 | 0 | 5 | 5 |
2013 | 0 | 6 | 6 |
2014 | 2 | 3 | 5 |
2015 | 2 | 2 | 4 |
2016 | 1 | 1 | 2 |
2017 | 2 | 5 | 7 |
2018 | 3 | 4 | 7 |
2019 | 4 | 11 | 15 |
2020 | 2 | 7 | 9 |
2021 | 3 | 5 | 8 |
2022 | 1 | 2 | 3 |
2023 | 0 | 4 | 4 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oxidative Phosphorylation" by people in Profiles.
-
NADPH oxidase overexpression and mitochondrial OxPhos impairment are more profound in human hearts donated after circulatory death than brain death. Am J Physiol Heart Circ Physiol. 2024 Mar 01; 326(3):H548-H562.
-
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro. Biochem Pharmacol. 2024 Feb; 220:115981.
-
Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment. Oncogene. 2023 03; 42(14):1117-1131.
-
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat Med. 2023 01; 29(1):115-126.
-
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer. Mol Cancer Res. 2023 01 03; 21(1):51-61.
-
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors. Invest New Drugs. 2022 10; 40(5):1001-1010.
-
PGC1a/? Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer. Cancer Res. 2022 04 01; 82(7):1423-1434.
-
Protection of Quiescence and Longevity of IgG Memory B Cells by Mitochondrial Autophagy. J Immunol. 2022 03 01; 208(5):1085-1098.
-
Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome. PLoS Genet. 2021 12; 17(12):e1009971.
-
Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition. Blood Adv. 2021 10 26; 5(20):4233-4255.